Picton Mahoney Asset Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Picton Mahoney Asset Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,150,000	Closed	-$12M	–	527
2023 Q1	$12M	Buy	1,150,000 +1,000,000	+667%	+$10.4M	0.53%	55
2022 Q4	$1.54M	Hold	150,000	–	–	0.07%	331
2022 Q3	$1.5M	Hold	150,000	–	–	0.05%	380
2022 Q2	$1.5M	Hold	150,000	–	–	0.06%	457
2022 Q1	$1.48M	Buy	+150,000	New	+$1.48M	0.05%	483

Other funds holding BIOS

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.28% 1-Year Est. Return

MSU

Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

WRBC

W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

Quarry LP New York $558M AUM 23.81% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Picton Mahoney Asset Management's BIOS Position: Q2 2023 in Review

Picton Mahoney Asset Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q2 2023, closing a stake of 1,150,000 shares — an estimated $12M sold.

Picton Mahoney Asset Management first reported a position in BIOS in Q1 2022 and held it in 5 quarters. The position peaked at $12M in Q1 2023. 32 funds tracked by Wall St. Rank hold BIOS as of Q2 2023.

Picton Mahoney Asset Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 1,150,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q2 2023, an estimated $12M.
Picton Mahoney Asset Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 5 quarters.
Picton Mahoney Asset Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $12M in Q1 2023.
32 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q2 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2023, filed 3 Aug 2023.